To further investigate whether the RECK-induced obstacle of growth and metastasis is caused by modulation of ERK/MAPK signaling, GC cells were treated with an ERK inhibitor, PD98059, and an ERK activator, TBHQ. The gene discussed is RECK; the disease is gastric cancer.